JP2022533621A5 - - Google Patents
Info
- Publication number
- JP2022533621A5 JP2022533621A5 JP2021568290A JP2021568290A JP2022533621A5 JP 2022533621 A5 JP2022533621 A5 JP 2022533621A5 JP 2021568290 A JP2021568290 A JP 2021568290A JP 2021568290 A JP2021568290 A JP 2021568290A JP 2022533621 A5 JP2022533621 A5 JP 2022533621A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2019/087260 | 2019-05-16 | ||
| CN2019087260 | 2019-05-16 | ||
| PCT/CN2020/090601 WO2020228825A1 (en) | 2019-05-16 | 2020-05-15 | Engineered immune cells comprsing a recognition molecule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022533621A JP2022533621A (ja) | 2022-07-25 |
| JP2022533621A5 true JP2022533621A5 (https=) | 2024-01-25 |
Family
ID=73289800
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568290A Withdrawn JP2022533621A (ja) | 2019-05-16 | 2020-05-15 | 認識分子を含む操作された免疫細胞 |
| JP2021568274A Ceased JP2022534680A (ja) | 2019-05-16 | 2020-05-15 | Ｃｄ４結合部分を含む免疫細胞受容体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568274A Ceased JP2022534680A (ja) | 2019-05-16 | 2020-05-15 | Ｃｄ４結合部分を含む免疫細胞受容体 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20220265711A1 (https=) |
| EP (2) | EP3969572A4 (https=) |
| JP (2) | JP2022533621A (https=) |
| KR (2) | KR20220010722A (https=) |
| CN (3) | CN118420762A (https=) |
| AU (2) | AU2020275049A1 (https=) |
| SG (2) | SG11202112554UA (https=) |
| WO (2) | WO2020228824A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202110873A (zh) | 2019-04-30 | 2021-03-16 | 美商聖堤生物科技股份有限公司 | 嵌合受體及其使用方法 |
| EP4291573A4 (en) * | 2021-02-09 | 2025-01-29 | Nanjing Legend Biotech Co., Ltd. | Engineered cells and uses thereof |
| GB202105684D0 (en) * | 2021-04-21 | 2021-06-02 | Imperial College Innovations Ltd | Chimeric antigen receptor (CAR)-T cells |
| EP4381081A1 (en) | 2021-08-04 | 2024-06-12 | Sana Biotechnology, Inc. | Use of cd4-targeted viral vectors |
| WO2023114949A1 (en) | 2021-12-16 | 2023-06-22 | Sana Biotechnology, Inc. | Methods and systems of particle production |
| EP4463135A2 (en) | 2022-01-10 | 2024-11-20 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2023150647A1 (en) | 2022-02-02 | 2023-08-10 | Sana Biotechnology, Inc. | Methods of repeat dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2023193015A1 (en) | 2022-04-01 | 2023-10-05 | Sana Biotechnology, Inc. | Cytokine receptor agonist and viral vector combination therapies |
| WO2024026377A1 (en) | 2022-07-27 | 2024-02-01 | Sana Biotechnology, Inc. | Methods of transduction using a viral vector and inhibitors of antiviral restriction factors |
| US20260055146A1 (en) | 2022-08-24 | 2026-02-26 | Sana Biotechnology, Inc. | Delivery of heterologous proteins |
| CN116063501A (zh) * | 2022-08-29 | 2023-05-05 | 华道(上海)生物医药有限公司 | 一种抗cd4抗体及其用途 |
| WO2024064838A1 (en) | 2022-09-21 | 2024-03-28 | Sana Biotechnology, Inc. | Lipid particles comprising variant paramyxovirus attachment glycoproteins and uses thereof |
| CN115819622A (zh) * | 2022-09-26 | 2023-03-21 | 湖南省人民医院(湖南师范大学附属第一医院) | 针对b系白血病或淋巴瘤的双靶点car结构及药物组合物 |
| WO2024119157A1 (en) | 2022-12-02 | 2024-06-06 | Sana Biotechnology, Inc. | Lipid particles with cofusogens and methods of producing and using the same |
| WO2024220597A2 (en) | 2023-04-18 | 2024-10-24 | Sana Biotechnology, Inc. | Digital droplet based assay for detecting replication competent lentiviral vector |
| CN116836284A (zh) * | 2023-04-21 | 2023-10-03 | 浙江正熙生物技术有限公司 | 一种抗人cd4抗体及其制备方法和应用 |
| EP4716750A1 (en) | 2023-05-23 | 2026-04-01 | Sana Biotechnology, Inc. | Tandem fusogens and related lipid particles |
| CN121941762A (zh) * | 2023-09-25 | 2026-04-28 | 詹森生物科技公司 | 用于产生工程化细胞和/或可工程化细胞的组合物和方法 |
| WO2025184529A1 (en) | 2024-03-01 | 2025-09-04 | Sana Biotechnology, Inc. | Viral particles with fusogen display and related compositions and methods |
| WO2026032970A1 (en) | 2024-08-07 | 2026-02-12 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Cd4-specific chimeric antigen receptor and methods and uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006281803B9 (en) * | 2005-08-18 | 2013-05-30 | Genmab A/S | Therapy with CD4 binding peptides and radiation |
| CA2861491C (en) * | 2012-02-13 | 2020-08-25 | Seattle Children's Hospital D/B/A Seattle Children's Research Institute | Bispecific chimeric antigen receptors and therapeutic uses thereof |
| RU2658485C2 (ru) * | 2012-10-24 | 2018-06-21 | Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез | Химерные антигенные рецепторы м971 |
| JP6839074B2 (ja) * | 2014-09-17 | 2021-03-03 | ノバルティス アーゲー | 養子免疫療法のためのキメラ受容体での細胞毒性細胞のターゲティング |
| PL3560953T3 (pl) * | 2014-12-24 | 2024-05-13 | Autolus Limited | Komórka |
| JP7237449B2 (ja) * | 2015-02-27 | 2023-03-13 | アイセル・ジーン・セラピューティクス・エルエルシー | 血液系腫瘍を標的としたキメラ抗体受容体（ＣＡＲｓ）の構成およびその使用方法 |
| JP6961490B2 (ja) * | 2015-04-08 | 2021-11-05 | ノバルティス アーゲー | Ｃｄ２０療法、ｃｄ２２療法、およびｃｄ１９キメラ抗原受容体（ｃａｒ）発現細胞との併用療法 |
| AU2016274989A1 (en) * | 2015-06-12 | 2017-11-02 | Immunomedics, Inc. | Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs |
| GB201601077D0 (en) * | 2016-01-20 | 2016-03-02 | Ucb Biopharma Sprl | Antibody molecule |
| WO2017177175A1 (en) * | 2016-04-07 | 2017-10-12 | The George Washington University | Methods and compositions targeting retroviral latency |
| KR20190071677A (ko) * | 2016-08-13 | 2019-06-24 | 유나이티드 바이오파마, 인크. | Haart 안정화된 환자에서 cd4에 대한 항체에 의한 hiv 감염의 치료 및 지속적 바이러스 완화 |
| ES2981703T3 (es) * | 2016-09-02 | 2024-10-10 | Lentigen Tech Inc | Composiciones y métodos para tratar cáncer con DuoCars |
| CN107964549B (zh) * | 2016-10-20 | 2020-12-08 | 上海恒润达生生物科技有限公司 | 靶向cd22的嵌合抗原受体及其用途 |
| WO2019020733A1 (en) * | 2017-07-26 | 2019-01-31 | Cellectis | METHODS OF IMMUNE CELL SELECTION OF THE ANTIGEN-DEPENDENT CHIMERIC ANTIGENIC RECEPTOR (CAR) |
| AU2019302603A1 (en) * | 2018-07-13 | 2021-01-14 | Nanjing Legend Biotech Co., Ltd. | Co-receptor systems for treating infectious diseases |
-
2020
- 2020-05-15 AU AU2020275049A patent/AU2020275049A1/en not_active Abandoned
- 2020-05-15 KR KR1020217038372A patent/KR20220010722A/ko not_active Withdrawn
- 2020-05-15 SG SG11202112554UA patent/SG11202112554UA/en unknown
- 2020-05-15 US US17/611,542 patent/US20220265711A1/en not_active Abandoned
- 2020-05-15 CN CN202410461081.9A patent/CN118420762A/zh not_active Withdrawn
- 2020-05-15 SG SG11202112536UA patent/SG11202112536UA/en unknown
- 2020-05-15 AU AU2020274569A patent/AU2020274569A1/en not_active Abandoned
- 2020-05-15 CN CN202080036396.9A patent/CN113825766A/zh active Pending
- 2020-05-15 JP JP2021568290A patent/JP2022533621A/ja not_active Withdrawn
- 2020-05-15 CN CN202080036374.2A patent/CN113840912A/zh active Pending
- 2020-05-15 EP EP20806230.7A patent/EP3969572A4/en not_active Withdrawn
- 2020-05-15 JP JP2021568274A patent/JP2022534680A/ja not_active Ceased
- 2020-05-15 EP EP20806600.1A patent/EP3969471A4/en active Pending
- 2020-05-15 WO PCT/CN2020/090600 patent/WO2020228824A1/en not_active Ceased
- 2020-05-15 KR KR1020217038368A patent/KR20220009966A/ko not_active Withdrawn
- 2020-05-15 WO PCT/CN2020/090601 patent/WO2020228825A1/en not_active Ceased
- 2020-05-15 US US17/611,543 patent/US20220241330A1/en active Pending